Cirujano General

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Cirujano General >Year 2011, Issue 2

Rodea-Rosas H, Valadez-Caballero D, Gutiérrez-Banda C, Sánchez-González A, Galindo-González F, Athié-Gutiérrez C
Prevalence of diabetes mellitus secondary to pancreatic necrosectomy
Cir Gen 2011; 33 (2)

Language: Español
References: 35
Page: 91-96
PDF: 4. Kb.

Full text


Objective: To report on the prevalence of diabetes mellitus secondary to necrosectomy due to septic complication of severe acute pancreatitis.
Setting: General Hospital of Mexico.
Design: Clinical comparative, observational, longitudinal, transversal, retrospective study.
Statistical analysis: Central tendency measures, Chi square (χ2) and Student’s t tests.
Material and methods: We evaluated all consecutive patients with a diagnosis of diabetes mellitus secondary (DMS) to a necrosectomy due to septic complication of severe acute pancreatitis (SAP) cared for between January 1st 1999 and December 31st 2009, older than 18 years, of either sex, alive at the time of follow-up, and a follow-up of 12 months. Assessed variables were: age, gender, etiology, degree of necrosis, number of pancreatic debridements, in-hospital stay days, days of Intensive Care Unit stay, scores of preoperative Ranson, APACHE II, and Balthazar, fasting glycemia at 1, 6, and 12 months after the last surgery to detect patients with DMS.
Results: From a total of 137 patients with septic complications of SAP and necrosectomy, 67 were excluded: 33 (24%) due to death, 26 (18.9%) because of incomplete follow up, and 8 (5.8%) because of DM before the acute pancreatitis event, this left 70 patients of which 46 (65.7 %) developed DMS; etiology was alcoholic in 36 (51.4%), biliary in 31 (44.3%), and other causes in 3 (4.3%). Tomography evaluation revealed 10 (14.3%) cases with Balthazar C, 20 (28.6%) with D, and 40 (57.1%) with E. Pancreatic debridements performed were: 1 in 18 patients (25.8%), 2 in 12 (17.1%), 3 in 12 (17.1%), 4 in 13 (18.6%), and 5 or more in 15 cases (21.4%). Average in-hospital stay and in the Intensive Care Unit was 21.6 (range 10-48) days and 14.2 (range 5-28) days, respectively. The average Ranson score was of 2.8 (range 2-6) and average preoperative APACHE II was of 12 (range 8-28). DMS was detected in most patients shortly after their hospital discharge; in 82.6% at 4 weeks, in 17.4% at 6 months, and none at 12 months after the last necrosectomy. CAT evidenced a higher frequency of DM in those patients classified with E (P ‹ 0.0001), as well as with more than 4 debridements, with a P ‹ 0.001.
Conclusions: Prevalence of DMS in patients with infected pancreatic necrosis, post-necrosectomy was of 65.7%, and it is related with a Balthazar E score by means of CAT, and with 4 or more debridements.

Key words: Pancreatitis, necrosectomy, diabetes mellitus, complications.


  1. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11-13, 1992. Arch Surg 1993; 128: 586-590.

  2. Working Party of the British Society of Gastroenterology; Association of Surgeons of Great Britain and Ireland; Pancreatic Society of Great Britain and Ireland; Association of Upper GI Surgeons of Great Britain and Ireland. UK Guidelines for the management of acute pancreatitis. Gut 2005; 54(Suppl 3): iii1-iii9.

  3. Ferat-Osorio E, Wong-Baeza I, Esquivel-Callejas N, Figueroa-Figueroa S, Duarte-Rojo A, Guzman-Valdivia-Gomez G, Rodea Rosas H, et al. Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Critical Care 2009; 13: R69.

  4. Beger HG, Rau B, Isenmann R. Natural history of necrotizing pancreatitis. Pancreatology 2003; 3: 93-101.

  5. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, et al. Early prediction of severity in acute pancreatitis by urinary tripsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955-1960.

  6. Brown A, Young B, Morton J, Behrns K, Shaheen N. Are health related outcomes in acute pancreatitis improving? An analysis of national trends in the U.S. from 1997 to 2003. JOP 2008; 9(4): 408-414.

  7. Wang GJ, Gao CF, Wei D, Wang C, Ding SQ. Acute pancreatitis: Etiology and common pathogenesis. World J Gastroenterol 2009; 15(12): 1427-1430.

  8. Wilson PG, Manji M, Neoptolemos JP. Acute pancreatitis as a model of sepsis. J Antimicrob Chemother 1998; 41(Supl A): 51-63.

  9. Hartwig W, Werner J, Uhl W, Büchler M. Management of infection in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 423-428.

  10. Neoptolemos JP, Raraty M, Finch M, Sutton R. Acute pancreatitis: the substantial human and financial costs. Gut 1998; 42: 886-891.

  11. Karsenti D, Bourlier P, Dorval E, Scotto B, Giraudeau B, Lanotte R, et al. Morbidity and mortality of acute pancreatitis. Prospective study in a French university hospital. Presse Med 2002; 31(16): 727-734.

  12. Leppaniemi A, Kemppainen E. Recent advances in the surgical management of necrotizing pancreatitis. Curr Opin Crit Care 2005; 11: 349-52.

  13. Büchler MW, Gloor B, Müller CA, Friess H, Seiler CA, Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 2000; 232(5): 619-626.

  14. Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999; 86(8): 1020-1024.

  15. Connor S, Alexakis N, Raraty MGT, Ghaneh P, Evans J, Hughes M, et al. Early and late complications after pancreatic necrosectomy. Surgery. 2005; 137: 499-505.

  16. Mayumi T, Takada T, Kawarada Y, Hirata K, Yoshida M, Sekimoto M, et al. Management strategy for acute pancreatitis in the JPN Guidelines. J Hepatobiliary Pancreat Surg 2006; 13(1): 61-67.

  17. Werner J, Feuerbach S, Uhl W, Büchler MW. Management of acute pancreatitis: from surgery to interventional intensive care. Gut 2005; 54: 426-436.

  18. Charnley RM, Lochan R, Gray H, O’Sullivan CB, Scott J, Oppong KE. Endoscopic necrosectomy as primary therapy in the management of infected pancreatic necrosis. Endoscopy 2006; 38(9): 925-528.

  19. Baker S. Diagnosis and management of acute pancreatitis. Crit Care Resusc 2004; 6(1): 17–27.

  20. Bradley EL, Howard TJ, Sonnenberg E, Fotoohi M. Intervention in necrotizing pancreatitis: an evidence-based review of surgical and percutaneous alternatives. J Gastrointest Surg 2008; 12(4): 634-639.

  21. Fernandez-del Castillo C, Rattner DW, Makary MA, Mostafavi A, McGrath D, Warshaw AL. Debridement and closed packing for the treatment of necrotizing pancreatitis. Ann Surg 1998; 228(5): 676-684.

  22. Paye F, Frileux P, Lehman P, Olivier JM, Vaillant JC, Parc R. Reoperation for severe pancreatitis: A 10-year experience in a tertiary care center. Arch Surg 1999; 134(3): 316-320.

  23. Uhl W, Warshaw A, Imrie C, Bassi C, McKay CJ, Lankisch, et al. International Association of Pancreatology. IAP guidelines for the surgical management of acute pancreatitis. Pancreatology 2002; 2(6): 565-573.

  24. Haney JC, Pappas TN. Necrotizing pancreatitis: diagnosis and management. Surg Clin N Am 2007; 87(6): 1431-1446.

  25. Pfützer RH, Whitcomb DC. Acute Pancreatitis. Curr Opin Gastroenterol 2000; 16(5): 410-413.

  26. Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 2002; 223(3): 603-613.

  27. Sabater L, Pareja E, Aparisi L, Calvete J, Camps B, Sastre J, et al Pancreatic function after severe acute biliary pancreatitis: the role of necrosectomy. Pancreas 2004; 28(1): 65-68.

  28. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26(11): 3160-3167.

  29. Bavare C, Prabhu R, Supe A. Early morphological and functional changes in pancreas following necrosectomy for acute severe necrotizing pancreatitis. Indian J Gastroenerology 2004; 23: 203-205.

  30. Tsiotos GC, Luque-de-León E, Sarr G. Long Term outcome for necrotizing pancreatitis treated by necrosectomy. Br J Surg 1998; 85: 1650-1653.

  31. Young SP, Thompson JP. Severe acute pancreatitis. Contin Educ Anaesth Crit Care Pain 2008; 8: 125-8.

  32. Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut 2008; 57(12): 1698-1703.

  33. Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand JA, et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 2004; 32(12): 2524-2536.

  34. Bradley EL 3rd, Dexter ND. Management of severe acute pancreatitis: a surgical odyssey. Ann Surg 2010; 251(1): 6-17.

  35. Williams EJ, Green J, Beckingham I, Parks R, Martin D, Lombard M; British Society of Gastroenterology. Guidelines on the management of common bile duct stones (CBDS). Gut 2008; 57(7): 1004-1021.

>Journals >Cirujano General >Year 2011, Issue 2

· Journal Index 
· Links 

Copyright 2019